83 FR 28652 - National Cancer Institute; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 83, Issue 119 (June 20, 2018)
National Institutes of Health
Federal Register Volume 83, Issue 119 (June 20, 2018)
| Page Range | 28652-28653 | |
| FR Document | 2018-13263 |
[Federal Register Volume 83, Number 119 (Wednesday, June 20, 2018)] [Notices] [Pages 28652-28653] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-13263] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. [[Page 28653]] The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant and/or contract applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with grant and/or contract applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Special Emphasis Panel for Contract Review. Date: July 10, 2018. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W530, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Shamala Srinivas, Ph.D., Scientific Review Officer, Office of Referral, Review, and Program Coordination, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W530, Bethesda, MD 20892-9750, 240- 276-6442, [email protected]. Name of Committee: National Cancer Institute Initial Review Group; Subcommittee A--Cancer Centers. Date: July 19, 2018. Time: 8:00 a.m. to 3:45 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Shamala Srinivas, Ph.D., Scientific Review Officer, Office of Referral, Review, and Program Coordination, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W530, Bethesda, MD 20892-9750, 240- 276-6442, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: June 13, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018-13263 Filed 6-19-18; 8:45 am] BILLING CODE 4140-01-P
![28652 Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices
Vulnerabilities and Actionable DEPARTMENT OF HEALTH AND maintenance, dissemination and
Process Steps HUMAN SERVICES adoption of named code sets; (3) Discuss
• Chapter Three—Mitigation Strategies opportunities for improved governance,
National Committee on Vital and Health coordination and communication across
for Actionable Process Steps
Statistics: Meeting terminology and vocabulary developers
• Chapter Four—Mitigation Strategies and their stakeholders; (4) Identify top
Management Components: Food Pursuant to the Federal Advisory
priority gaps in the U.S. health
Defense Monitoring Committee Act, the Department of
terminology and vocabulary coverage;
Health and Human Services (HHS)
• Appendix—Food Defense Plan announces the following advisory
and (5) Envision a roadmap for
Worksheets introducing improvements over the next
committee meeting.
Name: National Committee on Vital decade. Invited experts will have the
We intend to announce the
and Health Statistics (NCVHS), opportunity to provide extensive input
availability for public comment of
Standards Subcommittee Meeting. to the subcommittee as it studies these
additional and expanded chapters of the questions and finalizes an
draft guidance as we complete them. Date and Times: Tuesday, July 17,
2018: 9:00 a.m.–5:00 p.m. (EDT), Environmental Scan report of the
II. Significance of Guidance Wednesday, July 18, 2018: 8:30 a.m.– current state of the U.S. health
3:00 p.m. (EDT) terminology and vocabulary (T/V)
This level 1 draft guidance is being Place: U.S. Department of Health and environment.
issued consistent with FDA’s good Human Services, Hubert H. Humphrey The times and topics for this meeting
guidance practices regulation (21 CFR Building, 200 Independence Avenue are subject to change. Please refer to the
10.115). The draft guidance, when SW, Rm. 705A, Washington, DC 20201. posted agenda for any updates.
finalized, will represent the current Status: Open. There will be three Contact Persons for More Information:
thinking of FDA on food defense opportunities for public comment Substantive program information may
measures against intentional during the meeting: At the end of the be obtained from Rebecca Hines, MHS,
adulteration for the regulation first day, at the end of the morning of Executive Secretary, NCVHS, National
‘‘Mitigation Strategies to Protect Food the second day, and prior to the meeting Center for Health Statistics, Centers for
Against Intentional Adulteration.’’ It close on the second day. Disease Control and Prevention, 3311
does not establish any rights for any Purpose: The NCVHS Charter Toledo Road, Hyattsville, Maryland
person and is not binding on FDA or the stipulates that the Committee study the 20782, telephone (301) 458–4715.
public. You can use an alternative issues related to the adoption of uniform Information pertaining to meeting
approach if it satisfies the requirements data standards for patient medical content may be obtained from Vivian
of the applicable statutes and record information and the electronic Auld, National Institutes of Health,
regulations. This guidance is not subject exchange of such information and report National Library of Medicine, 8600
to Executive Order 12866. to the Secretary of Health and Human Rockville Pike, Bethesda, Maryland,
Services (HHS) with recommendations 20894–3833, telephone (301) 496–7974.
III. Paperwork Reduction Act of 1995 and legislative proposals for such Summaries of meetings and a roster of
standards and electronic exchange. Committee members are available on the
This draft guidance refers to NCVHS also is charged with advising NCVHS website: www.ncvhs.hhs.gov,
previously approved collections of HHS on health data collection needs where further information including a
information found in FDA regulations. and strategies, and reviewing and meeting agenda and instructions to
These collections of information are monitoring the Department’s data and access the live audio broadcast of the
subject to review by the Office of information systems to identify needs, meeting will be posted.
Management and Budget (OMB) under opportunities, and problems. Should you require reasonable
the Paperwork Reduction Act of 1995 In this regard, NCVHS is taking a accommodation, please contact the CDC
(44 U.S.C. 3501–3520). The collections contemporary look at the health Office of Equal Employment
of information in 21 CFR part 507 have terminology and vocabulary landscape Opportunity on (770) 488–3210 as soon
been approved under OMB control in order to advise the HHS Secretary as possible.
number 0910–0789. regarding: (1) The changing
Dated: June 14, 2018.
environment and implications for
IV. Electronic Access timing and approach to health Laina Bush,
terminology and vocabulary standards Deputy Assistant Secretary for Planning and
Persons with access to the internet Evaluation, Office of the Assistant Secretary
may obtain the draft guidance at either adoption; (2) Needs, opportunities, and
for Planning and Evaluation.
https://www.fda.gov/Regulatory problems with development,
dissemination, maintenance, and [FR Doc. 2018–13179 Filed 6–19–18; 8:45 am]
Information/Guidances/default.htm or
adoption of health terminology and BILLING CODE 4151–05–P
https://www.regulations.gov. Use the
vocabulary standards; and (3) Actions
FDA website listed in the previous
that HHS might take to improve
sentence to find the most current development, dissemination, DEPARTMENT OF HEALTH AND
version of the guidance. maintenance, and adoption of HUMAN SERVICES
Dated: June 12, 2018. standards. National Institutes of Health
NCVHS is holding an expert
sradovich on DSK3GMQ082PROD with NOTICES
Leslie Kux,
Associate Commissioner for Policy. roundtable meeting, in conjunction with National Cancer Institute; Notice of
the National Library of Medicine (NLM) Closed Meetings
[FR Doc. 2018–13222 Filed 6–19–18; 8:45 am]
in order to: (1) Assess strengths,
BILLING CODE 4164–01–P
weaknesses and gaps in the U.S. health Pursuant to section 10(d) of the
terminology and vocabulary (T/V) Federal Advisory Committee Act, as
environment; (2) Consider areas for near amended, notice is hereby given of the
term improvement in the development, following meetings.
VerDate Sep<11>2014 17:58 Jun 19, 2018 Jkt 244001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\20JNN1.SGM 20JNN1](https://thefederalregister.org/doc/83_FR_28771/page/1.svg)
![Federal Register / Vol. 83, No. 119 / Wednesday, June 20, 2018 / Notices 28653
The meetings will be closed to the DEPARTMENT OF HEALTH AND The meetings will be closed to the
public in accordance with the HUMAN SERVICES public in accordance with the
provisions set forth in sections provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant and/or contract as amended. The grant applications and
National Institute of General Medical the discussions could disclose
applications and the discussions could
Sciences; Notice of Closed Meeting confidential trade secrets or commercial
disclose confidential trade secrets or
commercial property such as patentable Pursuant to section 10(d) of the property such as patentable material,
material, and personal information Federal Advisory Committee Act, as and personal information concerning
concerning individuals associated with amended, notice is hereby given of the individuals associated with the grant
grant and/or contract applications, the following meeting. applications, the disclosure of which
disclosure of which would constitute a The meeting will be closed to the would constitute a clearly unwarranted
public in accordance with the invasion of personal privacy.
clearly unwarranted invasion of
personal privacy. provisions set forth in sections Name of Committee: Center for Scientific
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Review Special Emphasis Panel;
Name of Committee: National Cancer as amended. The grant applications and Cardiovascular and Respiratory Academic
Institute Special Emphasis Panel; Special the discussions could disclose Research Enhancement Awards.
Emphasis Panel for Contract Review. confidential trade secrets or commercial Date: July 12, 2018.
Date: July 10, 2018. Time: 10:00 a.m. to 3:00 p.m.
property such as patentable material,
Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant
and personal information concerning applications.
Agenda: To review and evaluate contract individuals associated with the grant Place: National Institutes of Health, 6701
proposals. applications, the disclosure of which Rockledge Drive, Bethesda, MD 20892.
Place: National Cancer Institute, Shady would constitute a clearly unwarranted Contact Person: Abdelouahab Aitouche,
Grove, 9609 Medical Center Drive, Room invasion of personal privacy. Ph.D., Scientific Review Officer, Center for
7W530, Rockville, MD 20850 (Telephone Scientific Review, National Institutes of
Conference Call). Name of Committee: National Institute of Health, 6701 Rockledge Drive, Room 4222,
General Medical Sciences Special Emphasis MSC 7814, Bethesda, MD 20892, 301–435–
Contact Person: Shamala Srinivas, Ph.D.,
Panel; Review of IPERT Applications. 2365, aitouchea@csr.nih.gov.
Scientific Review Officer, Office of Referral, Date: July 26, 2018.
Review, and Program Coordination, Division Time: 8:30 a.m. to 5:00 p.m. Name of Committee: Center for Scientific
of Extramural Activities, National Cancer Agenda: To review and evaluate grant Review Special Emphasis Panel; PAR18–596:
Institute, NIH, 9609 Medical Center Drive, applications. Molecular Mechanisms of Alzheimer’s
Room 7W530, Bethesda, MD 20892–9750, Place: Washington Marriott at Metro Disease, Synaptic Function and
240–276–6442, ss537t@nih.gov. Center, 775 12th Street NW, Washington, DC Neurodevelopment.
20005. Date: July 17, 2018.
Name of Committee: National Cancer Time: 10:00 a.m. to 4:00 p.m.
Contact Person: Lisa A. Dunbar, Ph.D.,
Institute Initial Review Group; Subcommittee Agenda: To review and evaluate grant
Scientific Review Officer, Office of Scientific
A—Cancer Centers. Review, National Institute of General Medical applications.
Date: July 19, 2018. Sciences, National Institutes of Health, 45 Place: National Institutes of Health, 6701
Time: 8:00 a.m. to 3:45 p.m. Center Drive, Room 3AN12, Bethesda, MD Rockledge Drive, Bethesda, MD 20892,
Agenda: To review and evaluate grant 20892, 301–594–2849, dunbarl@mail.nih.gov. (Virtual Meeting).
applications. Contact Person: Carol Hamelink, Ph.D.,
(Catalogue of Federal Domestic Assistance Scientific Review Officer, Center for
Place: Bethesda Marriott Suites, 6711 Program Nos. 93.375, Minority Biomedical Scientific Review, National Institutes of
Democracy Boulevard, Bethesda, MD 20817. Research Support; 93.821, Cell Biology and Health, 6701 Rockledge Drive, Room 4192,
Contact Person: Shamala Srinivas, Ph.D., Biophysics Research; 93.859, Pharmacology, MSC 7850, Bethesda, MD 20892, (301) 213–
Scientific Review Officer, Office of Referral, Physiology, and Biological Chemistry 9887, hamelinc@csr.nih.gov.
Review, and Program Coordination, Division Research; 93.862, Genetics and
Developmental Biology Research; 93.88, Name of Committee: Center for Scientific
of Extramural Activities, National Cancer Review Special Emphasis Panel; PAR Panel:
Minority Access to Research Careers; 93.96,
Institute, NIH, 9609 Medical Center Drive, Amyloid Polymorphisms and Gylcosylation
Special Minority Initiatives; 93.859,
Room 7W530, Bethesda, MD 20892–9750, Biomedical Research and Research Training, in Alzheimer’s Disease.
240–276–6442, ss537t@nih.gov. National Institutes of Health, HHS) Date: July 17, 2018.
(Catalogue of Federal Domestic Assistance Time: 10:00 a.m. to 6:00 p.m.
Dated: June 14, 2018. Agenda: To review and evaluate grant
Program Nos. 93.392, Cancer Construction;
David D. Clary, applications.
93.393, Cancer Cause and Prevention Place: National Institutes of Health, 6701
Research; 93.394, Cancer Detection and Program Analyst, Office of Federal Advisory
Committee Policy. Rockledge Drive, Bethesda, MD 20892,
Diagnosis Research; 93.395, Cancer (Virtual Meeting).
Treatment Research; 93.396, Cancer Biology [FR Doc. 2018–13265 Filed 6–19–18; 8:45 am]
Contact Person: Brian H Scott, Ph.D.,
Research; 93.397, Cancer Centers Support; BILLING CODE 4140–01–P Scientific Review Officer, National Institutes
93.398, Cancer Research Manpower; 93.399, of Health, Center for Scientific Review, 6701
Cancer Control, National Institutes of Health, Rockledge Drive, Bethesda, MD 20892, 301–
HHS) DEPARTMENT OF HEALTH AND 827–7490, brianscott@mail.nih.gov.
HUMAN SERVICES Name of Committee: Center for Scientific
Dated: June 13, 2018. Review Special Emphasis Panel; Member
Melanie J. Pantoja, National Institutes of Health Conflict: Chemo/Dietary Prevention and
sradovich on DSK3GMQ082PROD with NOTICES
Program Analyst, Office of Federal Advisory Cancer Biomarkers.
Committee Policy.
Center for Scientific Review; Notice of Date: July 17, 2018.
Closed Meetings Time: 11:00 a.m. to 5:00 p.m.
[FR Doc. 2018–13263 Filed 6–19–18; 8:45 am]
Agenda: To review and evaluate grant
BILLING CODE 4140–01–P Pursuant to section 10(d) of the applications.
Federal Advisory Committee Act, as Place: National Institutes of Health, 6701
amended, notice is hereby given of the Rockledge Drive, Bethesda, MD 20892,
following meetings. (Telephone Conference Call).
VerDate Sep<11>2014 17:58 Jun 19, 2018 Jkt 244001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\20JNN1.SGM 20JNN1](https://thefederalregister.org/doc/83_FR_28771/page/2.svg)
Document Created: 2018-06-20 00:20:06
Document Modified: 2018-06-20 00:20:06
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | July 10, 2018. | |
| FR Citation | 83 FR 28652 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR